Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-10T07:09:09.086Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply to Comment on the London/Toronto Study

Published online by Cambridge University Press:  02 January 2018

Isaac M. Marks ,
Richard P. Swinson ,
Metin Başoǧlu ,
Homa Noshirvani ,
Klaus Kuch ,
Geraldine O'Sullivan  and
Paul T. Lelliott
Isaac M. Marks*
Affiliation:
Institute of Psychiatry, London SE5 8AF
Richard P. Swinson
Affiliation:
Toronto General Hospital and University of Toronto, Canada
Metin Başoǧlu
Affiliation:
Institute of Psychiatry, London
Homa Noshirvani
Affiliation:
Institute of Psychiatry, London
Klaus Kuch
Affiliation:
Toronto General Hospital and University of Toronto
Geraldine O'Sullivan
Affiliation:
Institute of Psychiatry, London
Paul T. Lelliott
Affiliation:
Institute of Psychiatry, London
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Reply
Information
The British Journal of Psychiatry , Volume 162 , Issue 6 , June 1993 , pp. 790 - 794
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alkubaisy, T., Marks, I. M., Logsdail, S., et al (1992) The role of exposure homework in phobia reduction: a controlled study. Behavior Therapy, 23, 599–621.CrossRefGoogle Scholar
Ballenger, J. C., Burrows, G. D., Dupont, R. L., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial: I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413–422.Google Scholar
Başoǧlu, M. (1993) Patterns and Predictors of Treatment Outcome in Panic Disorder and Agoraphobia Treated with Alprazolam and Exposure. PhD Dissertation, University of London.Google Scholar
Başoǧlu, M., Marks, I. M., Kilic, J., et al (1993) Alprazolam and exposure for panic disorder with agoraphobia: IV. Attribution of improvement to drug predicts subsequent relapse. (Submitted for publication.) Google Scholar
Burrows, G. D., Norman, T. R., Judd, F. K., et al (1990) Short-acting vs long-acting benzodiazepines: discontinuation effects in panic disorders. Journal of Psychiatric Research, 24 (suppl. 2), 65–72.Google Scholar
Cross-National Collaborative Panic Study, Second Phase Investigators (CNCPS) (1992) Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. British Journal of Psychiatry, 160, 191–201.CrossRefGoogle Scholar
Fyer, A., Liebowitz, M., Gorman, J., et al (1987) Discontinuation of alprazolam in panic patients. American Journal of Psychiatry, 144, 303–308.Google Scholar
Ghosh, A. & Marks, I. M. (1987) Self-treatment of agoraphobia by exposure. Behavior Therapy, 18, 3–16.Google Scholar
Katschnig, H., Stolk, J. M., Klerman, G. L., et al (1991) Discontinuation and long-term followup of participants in a clinical drug trial for panic disorder. Biological Psychiatry, 1, 657–660.Google Scholar
Klosko, J. S., Barlow, D. H., Tassinari, R. B., et al (1990) A comparison of alprazolam and behavior therapy in the treatment of panic disorder. Journal of Consulting and Clinical Psychology, 58, 77–84.Google Scholar
Lesser, I. M., Rubin, R. T., Rifkin, A., et al (1988) Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. Journal of Affective Disorders, 16, 49–58.Google Scholar
Maier, W., Roth, M., Argyle, N., et al (1991) Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder? European Archives of Psychiatry and Clinical Neurosciences, 241, 151–158.Google Scholar
Margraf, J., Ehlers, A., Roth, W. T., et al (1991) How “blind” are double-blind studies? Journal of Consulting and Clinical Psychology, 59, 184–187.Google Scholar
Noyes, R., Garvey, M. J., Cook, B., et al (1991) Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517–523.Google ScholarPubMed
Pecknold, J. C., Swinson, R. P., Kuch, K., et al (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial - III. Discontinuation effects. Archives of General Psychiatry, 45, 429–436.Google Scholar
Rickels, K., Schweizer, E., Weiss, S., et al (1993) Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50, 61–68.CrossRefGoogle Scholar
Schweizer, E., Rickels, K., Weiss, S., et al (1993) Maintenance drug treatment for panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Archives of General Psychiatry, 50, 51–60.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.